去细胞化
氧化应激
移植
间充质干细胞
丙二醛
细胞生物学
生物能学
干细胞
化学
角膜
角膜移植
活性氧
氧化磷酸化
间质细胞
过氧亚硝酸盐
线粒体
再生(生物学)
干细胞疗法
细胞
免疫学
坏死
癌症研究
男科
生物
病理
作者
Xinlin Yan,Guozhen Chen,Yi Guan,Jing Li,Yuchuan Wang,Shumei Yang,Xuan Li
标识
DOI:10.1021/acsami.6c15983
摘要
Corneal alkali burn causes persistent inflammation, fibrosis, neovascularization, and vision impairment. Although amniotic membrane (AM) transplantation and mesenchymal stem cell (MSC)-based therapies have shown therapeutic potential, their combined application as a tissue-engineered construct for alkali-induced corneal injury remains insufficiently explored. Here, we developed a decellularized AM-based bone marrow-derived MSC (BMSC) composite and evaluated its therapeutic effects in a mouse model of corneal alkali burn. Compared with AM transplantation or subconjunctival BMSC injection alone, the BMSC-AM composite more effectively reduced corneal opacity and neovascularization, restored epithelial integrity and stromal architecture, and suppressed inflammatory and fibrotic responses. Moreover, BMSC-AM treatment alleviated oxidative stress, as indicated by reduced reactive oxygen species and malondialdehyde accumulation and increased total antioxidant capacity. Seahorse mitochondrial stress analysis further demonstrated that the composite restored mitochondrial oxidative phosphorylation, with more pronounced effects at 14 days after injury. Collectively, this study establishes a decellularized AM-BMSC composite as a biomaterial-assisted therapeutic platform for corneal alkali injury and suggests that preservation of mitochondrial bioenergetics and attenuation of oxidative stress contribute to its reparative effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI